Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
6.28
+0.21 (3.38%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Trevi Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$17.56
Upside
+179.84%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Needham | Needham | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +282.47% | Apr 8, 2025 |
B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $11 → $20 | Strong Buy | Reiterates | $11 → $20 | +218.73% | Mar 19, 2025 |
Needham | Needham | Strong Buy Maintains $25 → $24 | Strong Buy | Maintains | $25 → $24 | +282.47% | Mar 19, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +234.66% | Mar 19, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +99.20% | Mar 19, 2025 |
Oppenheimer | Oppenheimer | Buy Maintains $12 → $20 | Buy | Maintains | $12 → $20 | +218.73% | Mar 11, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7.5 → $13 | Strong Buy | Maintains | $7.5 → $13 | +99.20% | Mar 10, 2025 |
Raymond James | Raymond James | Buy → Strong Buy Upgrades $9 → $29 | Buy → Strong Buy | Upgrades | $9 → $29 | +362.15% | Mar 10, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +234.66% | Mar 10, 2025 |
Needham | Needham | Strong Buy Maintains $8 → $25 | Strong Buy | Maintains | $8 → $25 | +298.41% | Mar 10, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +234.66% | Mar 7, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +234.66% | Feb 24, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +234.66% | Jan 8, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +234.66% | Dec 16, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 → $7.5 | Strong Buy | Reiterates | $6 → $7.5 | +19.52% | Dec 13, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $7.5 | Strong Buy | Maintains | $6 → $7.5 | +19.52% | Dec 12, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.